DAFNA Capital Management as of Dec. 31, 2015
Portfolio Holdings for DAFNA Capital Management
DAFNA Capital Management holds 77 positions in its portfolio as reported in the December 2015 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
AtriCure (ATRC) | 9.8 | $11M | 488k | 22.44 | |
NxStage Medical | 7.2 | $8.0M | 367k | 21.91 | |
Abbvie (ABBV) | 6.2 | $6.9M | 117k | 59.24 | |
Marinus Pharmaceuticals | 3.9 | $4.3M | 567k | 7.64 | |
Insulet Corporation (PODD) | 3.6 | $4.0M | 106k | 37.81 | |
Cti Biopharma | 3.5 | $3.9M | 3.2M | 1.23 | |
Aerie Pharmaceuticals | 3.2 | $3.6M | 148k | 24.35 | |
Vitae Pharmaceuticals | 3.1 | $3.5M | 193k | 18.10 | |
Rigel Pharmaceuticals (RIGL) | 3.0 | $3.4M | 1.1M | 3.03 | |
Applied Genetic Technol Corp C | 2.9 | $3.2M | 157k | 20.40 | |
Cara Therapeutics (CARA) | 2.5 | $2.9M | 169k | 16.86 | |
Biotelemetry | 2.5 | $2.8M | 236k | 11.68 | |
BioCryst Pharmaceuticals (BCRX) | 2.4 | $2.6M | 256k | 10.32 | |
Achillion Pharmaceuticals | 2.3 | $2.6M | 237k | 10.79 | |
Insulet Corp note 2.000% 6/1 | 2.2 | $2.5M | 2.4M | 1.04 | |
Masimo Corporation (MASI) | 1.7 | $1.9M | 46k | 41.51 | |
Galapagos Nv- (GLPG) | 1.7 | $1.9M | 30k | 62.87 | |
Protalix Biotherapeutics Inc note 4.500% 9/1 | 1.6 | $1.8M | 2.5M | 0.71 | |
Loxo Oncology | 1.6 | $1.8M | 62k | 28.44 | |
Synergy Pharmaceuticals | 1.5 | $1.7M | 295k | 5.67 | |
Celyad Sa | 1.5 | $1.6M | 30k | 54.60 | |
Derma Sciences | 1.4 | $1.6M | 354k | 4.57 | |
Tobira Therapeutics Inc Common Stock Usd 0.0001 | 1.4 | $1.6M | 160k | 10.05 | |
Discovery Laboratories | 1.4 | $1.6M | 7.5M | 0.21 | |
Cytrx | 1.4 | $1.5M | 583k | 2.65 | |
Dicerna Pharmaceuticals | 1.3 | $1.4M | 121k | 11.87 | |
Avalanche Biotechnologies In | 1.2 | $1.3M | 141k | 9.52 | |
Novadaq Technologies | 1.2 | $1.3M | 102k | 12.74 | |
Spectranetics Corporation | 1.1 | $1.2M | 80k | 15.06 | |
Nuvasive Inc. conv | 0.9 | $1.0M | 760k | 1.38 | |
Essa Pharma | 0.9 | $1.0M | 229k | 4.57 | |
Stereotaxis (STXS) | 0.9 | $1.0M | 1.4M | 0.74 | |
Zogenix | 0.9 | $1.0M | 69k | 14.74 | |
Scynexis | 0.9 | $974k | 157k | 6.21 | |
Ascendis Pharma A S (ASND) | 0.9 | $975k | 53k | 18.31 | |
Johnson & Johnson (JNJ) | 0.9 | $966k | 9.4k | 102.77 | |
Neos Therapeutics | 0.8 | $908k | 63k | 14.32 | |
Caredx (CDNA) | 0.8 | $871k | 136k | 6.40 | |
Regulus Therapeutics | 0.7 | $785k | 90k | 8.72 | |
Xenon Pharmaceuticals (XENE) | 0.7 | $786k | 98k | 8.04 | |
Macrogenics (MGNX) | 0.7 | $743k | 24k | 30.96 | |
Arena Pharmaceuticals | 0.7 | $725k | 382k | 1.90 | |
Cynapsus Therapeutics | 0.6 | $722k | 47k | 15.48 | |
Syneron Medical Ltd ord | 0.6 | $663k | 86k | 7.71 | |
Lipocine | 0.6 | $647k | 50k | 12.94 | |
Intec Pharma | 0.6 | $639k | 119k | 5.36 | |
Abeona Therapeutics | 0.5 | $611k | 182k | 3.36 | |
Alder Biopharmaceuticals | 0.5 | $595k | 18k | 33.06 | |
Uniqure Nv (QURE) | 0.5 | $579k | 35k | 16.54 | |
Adaptimmune Therapeutics (ADAP) | 0.5 | $580k | 48k | 12.06 | |
Exactech | 0.5 | $574k | 32k | 18.14 | |
Ironwood Pharma note 2.25% 15-jun-2022 144a sr unsecured conv | 0.5 | $564k | 600k | 0.94 | |
Endologix, Inc. 3.25% 11/01/2020 | 0.5 | $545k | 500k | 1.09 | |
Cynapsus Therapeutics | 0.5 | $526k | 34k | 15.47 | |
Targacept Inc Conv Dtd convertible | 0.5 | $531k | 531k | 1.00 | |
Foamix Pharmaceuticals | 0.4 | $493k | 61k | 8.11 | |
Vtv Therapeutics Inc- Cl A | 0.4 | $497k | 73k | 6.81 | |
Cogentix Medical | 0.4 | $454k | 352k | 1.29 | |
Tandem Diabetes Care | 0.4 | $432k | 37k | 11.82 | |
Cytokinetics (CYTK) | 0.4 | $418k | 40k | 10.45 | |
Bluebird Bio (BLUE) | 0.3 | $385k | 6.0k | 64.17 | |
Nemus Bioscience | 0.3 | $344k | 625k | 0.55 | |
Tenax Therapeutics | 0.2 | $261k | 80k | 3.28 | |
Catalyst Biosciences | 0.2 | $222k | 71k | 3.13 | |
Cardica | 0.2 | $210k | 1.4M | 0.15 | |
Check Cap | 0.2 | $206k | 109k | 1.89 | |
Genvec | 0.2 | $176k | 96k | 1.84 | |
Venaxis | 0.2 | $178k | 595k | 0.30 | |
Trevena | 0.1 | $155k | 15k | 10.47 | |
Pronai Therapeutics | 0.1 | $150k | 10k | 15.00 | |
Akari Therapeutics | 0.1 | $121k | 8.3k | 14.51 | |
Nivalis Therapeutics | 0.1 | $116k | 15k | 7.73 | |
Galmed Pharmaceuticals | 0.1 | $91k | 12k | 7.59 | |
EnteroMedics | 0.1 | $65k | 500k | 0.13 | |
Antares Pharma | 0.1 | $54k | 45k | 1.20 | |
Cel-sci | 0.0 | $47k | 128k | 0.37 | |
Check Cap Ltd w exp 02/28/202 | 0.0 | $38k | 54k | 0.71 |